Hazel T. Y. Cheng
Corporate Officer/Principal chez AbGenomics International, Inc.
Profil
Hazel T.
Y.
Cheng is currently the Vice President-Project & Alliance Managements at AbGenomics International, Inc. She holds a doctorate degree from National Taiwan University.
Postes actifs de Hazel T. Y. Cheng
| Sociétés | Poste | Début |
|---|---|---|
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Corporate Officer/Principal | - |
Formation de Hazel T. Y. Cheng
| National Taiwan University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
